PIK3CA mutations in human solid tumors Role in sensitivity to various therapeutic approaches

199Citations
Citations of this article
181Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Phosphatidylinositol 3-kinases (PI3Ks) are a group of lipid kinases that regulate signaling pathways involved in cell proliferation, adhesion, survival and motility. The PI3K pathway is considered to play an important role in tumorigenesis. Activating mutations of the p110α subunit of PI3K (PIK3CA) have been identified in a broad spectrum of tumors. Analyses of PIK3CA mutations reveals that they increase the PI3K signal, stimulate downstream Akt signaling, promote growth factor-independent growth and increase cell invasion and metastasis. In this review, we analyze the contribution of the PIK3CA mutations in cancer, and their possible implications for diagnosis and therapy. ©2009 Landes Bioscience.

Cite

CITATION STYLE

APA

Ligresti, G., Militello, L., Steelman, L. S., Cavallaro, A., Basile, F., Nicoletti, F., … Libra, M. (2009, May 1). PIK3CA mutations in human solid tumors Role in sensitivity to various therapeutic approaches. Cell Cycle. Taylor and Francis Inc. https://doi.org/10.4161/cc.8.9.8255

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free